Nyxoah Company Description

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions.

The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah S.A.

Country	Belgium
Founded	2009
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	147
CEO	Olivier Taelman

Contact Details

Address: Rue Edouard Belin 12 Mont-Saint-Guibert, 1435 Belgium
Phone	32 10 22 23 55
Website	nyxoah.com

Stock Details

Ticker Symbol	NYXH
Exchange	Euronext Brussels
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	BE0974358906
SIC Code	3841

Key Executives

Name	Position
Olivier Taelman	Chief Executive Officer and Executive Director
Robert Taub MBA	Co-Founder and Chairman
Loic Moreau	President of International
John Landry	Chief Financial Officer
Bruno Onkelinx	Chief Technology Officer
Mikaela Kirkwood	Corporate Communication and Investor Relations Manager
An Moonen	General Counsel
Maggie McGowan	Chief Human Resources Officer
Remi Renard	Chief of Staff
Jeyakumar Subbaroyan	Chief Clinical Officer